Objective Endothelial cells (ECs) play an important role in neovascularisation, but are too
limited in number for adequate therapeutic applications. Mesenchymal stem cells (MSCs) …

Abstract Background Mesenchymal stem cells (MSCs) can improve limb perfusion and
increase vessel density in a murine model of hindlimb ischemia. But low engraftment rate of …

Objective The aim was to identify the change in gene expression between mesenchymal
stem cells (MSCs) and induced endothelial cells (ECs) and to investigate the potential …

Background: Blood‐derived endothelial progenitor cells (EPC) have been used to treat
ischemic disease. However, the number of EPC that can be obtained from adult blood is …

Autologous vein grafts is still commonly used for arterial reconstructive procedures. Their
success is limited by the development of neointimal hyperplasia. Clinical and experimental …

Human bone marrow‐derived mesenchymal stem cells (MSCs) have the potential to
differentiate into mesenchymal tissues like osteocytes, chondrocytes, and adipocytes in vivo …

Mesenchymal stem cells (MSCs) hold potential for the regeneration of damaged tissues in
cardiovascular diseases. In this study, we investigated the potential of porcine MSCs to …

Stem cell therapy is a promising treatment strategy for ischemic diseases. Mesenchymal
stem cells (MSCs) and endothelial progenitor cells (EPCs) adhere to each other in the bone …

Endothelial progenitor cells (EPCs) and mesenchymal stem cells (MSCs) have emerged as
potentially useful substrates for neovascularization and tissue repair and bioengineering …

Mesenchymal stem cells (MSCs) have shown their therapeutic potency for treatment of
cardiovascular diseases owing to their low immunogenicity, ease of isolation and …